Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125618552 | 12561855 | 2 | F | 20160802 | 20160715 | 20160811 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055790 | BRISTOL MYERS SQUIBB | 53.00 | YR | F | Y | 0.00000 | 20160811 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125618552 | 12561855 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Unknown | 300 MG, QD | Y | 21567 | 300 | MG | QD | ||||||
| 125618552 | 12561855 | 2 | SS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Unknown | 200 MG, QD | Y | 21567 | 200 | MG | QD | ||||||
| 125618552 | 12561855 | 3 | SS | RITONAVIR. | RITONAVIR | 1 | Unknown | 100 MG, QD | Y | 0 | 100 | MG | QD | ||||||
| 125618552 | 12561855 | 4 | SS | OMBITASVIR | OMBITASVIR | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | QD | ||||||
| 125618552 | 12561855 | 5 | SS | DASABUVIR SODIUM MONOHYDRATE | DASABUVIR SODIUM MONOHYDRATE | 1 | Unknown | 250 MG, BID | Y | 0 | 250 | MG | BID | ||||||
| 125618552 | 12561855 | 6 | SS | PARITAPREVIR | PARITAPREVIR | 1 | Unknown | 150 MG, QD | Y | 0 | 150 | MG | QD | ||||||
| 125618552 | 12561855 | 7 | SS | RALTEGRAVIR. | RALTEGRAVIR | 1 | Unknown | 200 MG, BID | Y | 0 | 400 | MG | BID | ||||||
| 125618552 | 12561855 | 8 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125618552 | 12561855 | 1 | HIV infection |
| 125618552 | 12561855 | 3 | Hepatitis C |
| 125618552 | 12561855 | 4 | Hepatitis C |
| 125618552 | 12561855 | 5 | Hepatitis C |
| 125618552 | 12561855 | 6 | Hepatitis C |
| 125618552 | 12561855 | 7 | HIV infection |
| 125618552 | 12561855 | 8 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125618552 | 12561855 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125618552 | 12561855 | Drug interaction | |
| 125618552 | 12561855 | Hyperbilirubinaemia | |
| 125618552 | 12561855 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125618552 | 12561855 | 1 | 2009 | 0 | ||
| 125618552 | 12561855 | 2 | 201507 | 0 | ||
| 125618552 | 12561855 | 3 | 2009 | 201507 | 0 | |
| 125618552 | 12561855 | 4 | 20150701 | 0 | ||
| 125618552 | 12561855 | 5 | 20150701 | 0 | ||
| 125618552 | 12561855 | 6 | 20150701 | 0 | ||
| 125618552 | 12561855 | 7 | 2009 | 0 | ||
| 125618552 | 12561855 | 8 | 20150701 | 0 |